The Cooper Cos., Inc. (COO)
72.60
-0.44
(-0.60%)
USD |
NASDAQ |
Aug 26, 13:20
Cooper Cos. Cash from Operations (Quarterly) : 182.80M for April 30, 2026
Cash from Operations (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| April 30, 2026 | 182.80M |
| January 31, 2026 | 260.90M |
| October 31, 2025 | 247.90M |
| July 31, 2025 | 261.40M |
| April 30, 2025 | 96.20M |
| January 31, 2025 | 190.60M |
| October 31, 2024 | 268.10M |
| July 31, 2024 | 207.50M |
| April 30, 2024 | 111.00M |
| January 31, 2024 | 122.70M |
| October 31, 2023 | 174.20M |
| July 31, 2023 | 142.50M |
| April 30, 2023 | 124.20M |
| January 31, 2023 | 166.60M |
| October 31, 2022 | 130.70M |
| July 31, 2022 | 263.90M |
| April 30, 2022 | 131.80M |
| January 31, 2022 | 166.00M |
| October 31, 2021 | 174.50M |
| July 31, 2021 | 223.80M |
| April 30, 2021 | 192.60M |
| January 31, 2021 | 147.70M |
| October 31, 2020 | 218.30M |
| July 31, 2020 | 112.80M |
| April 30, 2020 | 25.80M |
| Date | Value |
|---|---|
| January 31, 2020 | 129.70M |
| October 31, 2019 | 199.90M |
| July 31, 2019 | 196.70M |
| April 30, 2019 | 214.80M |
| January 31, 2019 | 101.80M |
| October 31, 2018 | 236.60M |
| July 31, 2018 | 235.20M |
| April 30, 2018 | 170.90M |
| January 31, 2018 | 26.20M |
| October 31, 2017 | 199.00M |
| July 31, 2017 | 154.50M |
| April 30, 2017 | 131.70M |
| January 31, 2017 | 108.40M |
| October 31, 2016 | 193.34M |
| July 31, 2016 | 128.91M |
| April 30, 2016 | 97.85M |
| January 31, 2016 | 89.54M |
| October 31, 2015 | 104.52M |
| July 31, 2015 | 95.97M |
| April 30, 2015 | 110.64M |
| January 31, 2015 | 79.84M |
| October 31, 2014 | 152.06M |
| July 31, 2014 | 107.86M |
| April 30, 2014 | 126.33M |
| January 31, 2014 | 68.57M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Globus Medical, Inc. | 209.74M |
| West Pharmaceutical Services, Inc. | 124.00M |
| Abbott Laboratories | 2.488B |
| Stryker Corp. | 1.261B |
| Solventum Corp. | 227.00M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -90.00M |
| Cash from Financing (Quarterly) | -75.80M |
| Free Cash Flow | 569.50M |
| Free Cash Flow Per Share (Quarterly) | 0.4944 |
| Free Cash Flow to Equity (Quarterly) | 135.90M |
| Free Cash Flow to Firm (Quarterly) | 138.57M |
| Free Cash Flow Yield | 3.97% |